Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction
Circulation · 10.09.2024 · 150 (11) · 867-883
DOI: 10.1161/circulationaha.124.068624 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 10.09.2024. Verfasst von Jia-Rong Jheng und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care, Sleep and Occupational Medicine (J.-R.J., Y.B., T.C., A.F., R.F.M., Y.-C.L.), Indiana University School of Medi…. Hauptthemen laut MEDLINE: Sirtuin 3, Heart Failure, Vascular Remodeling, Hypertension, Pulmonary. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND: Pulmonary hypertension (PH) is a major complication linked to adverse outcomes in heart failure with preserved ejection fraction (HFpEF), yet no specific therapies exist for PH associated with HFpEF (PH-HFpEF). We have recently reported on the role of skeletal muscle SIRT3 (sirtuin-3) in modulation of PH-HFpEF, suggesting a novel endocrine signaling pathway for skeletal muscle modulation of pulmonary vascular remodeling. METHODS: Using skeletal muscle-specific Sirt3 knockout mice ( Sirt3 skm-/- ) and mass spectrometry-based comparative secretome analysis, we attempted to define the processes by which skeletal muscle SIRT3 defects affect pulmonary vascular health in PH-HFpEF. RESULTS: Sirt3 skm-/- mice exhibited reduced pulmonary vascular density accompanied by pulmonary vascular proliferative remodeling and elevated pulmonary pressures. Comparative analysis of secretome by mass spectrometry revealed elevated secretion levels of LOXL2 (lysyl oxidase homolog 2) in SIRT3-deficient skeletal muscle cells. Elevated circulation and protein expression levels of LOXL2 were also observed in plasma and skeletal muscle of Sirt3 skm-/- mice, a rat model of PH-HFpEF, and humans with PH-HFpEF. In addition, expression levels of CNPY2 (canopy fibroblast growth factor signaling regulator 2), a known proliferative and angiogenic factor, were increased in pulmonary artery endothelial cells and pulmonary artery smooth muscle cells of Sirt3 skm-/- mice and animal models of PH-HFpEF. CNPY2 levels were also higher in pulmonary artery smooth muscle cells of subjects with obesity compared with nonobese subjects. Moreover, treatment with recombinant LOXL2 protein promoted pulmonary artery endothelial cell migration/proliferation and pulmonary artery smooth muscle cell proliferation through regulation of CNPY2-p53 signaling. Last, skeletal muscle–specific Loxl2 deletion decreased pulmonary artery endothelial cell and pulmonary artery smooth muscle cell expression of CNPY2 and improved pulmonary pressures in mice with high-fat diet–induced PH-HFpEF. CONCLUSIONS: This study demonstrates a systemic pathogenic impact of skeletal muscle SIRT3 deficiency in remote pulmonary vascular remodeling and PH-HFpEF. This study suggests a new endocrine signaling axis that links skeletal muscle health and SIRT3 deficiency to remote CNPY2 regulation in the pulmonary vasculature through myokine LOXL2. Our data also identify skeletal muscle SIRT3, myokine LOXL2, and CNPY2 as potential targets for the treatment of PH -HFpEF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary, Critical Care, Sleep and Occupational Medicine (J.-R.J., Y.B., T.C., A.F., R.F.M., Y.-C.L.), Indiana University School of Medicine, Indianapolis.
- Department of Clinical Pharmacology, School of Pharmacy, China Medical University, Shenyang (Y.B.).
- Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, PA (K.N.).
- Department of Anatomy, Cell Biology and Physiology (J.R.H., R.F.M., Y.-C.L.), Indiana University School of Medicine, Indianapolis.
- Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan (Y.-Y.C.).
- Division of Pulmonary, Critical Care and Sleep Medicine, University of California, Davis (D.A.G., E.A.G.).
ORCID-Profile: Jia-Rong Jheng, Yang Bai, Kentaro Noda, Joshua R Huot, Yi-Yun Chen, Elena A Goncharova, Marc A Simon, Daniel E Forman, Yen-Chun Lai
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
Zitieren
APA
Jheng, J. R., Bai, Y., Noda, K., Huot, J. R., Cook, T., Fisher, A., Chen, Y. Y., Goncharov, D. A., Goncharova, E. A., Simon, M. A., Zhang, Y., Forman, D. E., Rojas, M., Machado, R. F., Auwerx, J., Gladwin, M. T., & Lai, Y. C. (2024). Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction. Circulation, 150(11), 867-883. https://doi.org/10.1161/circulationaha.124.068624
Vancouver
Jheng JR, Bai Y, Noda K, Huot JR, Cook T, Fisher A, et al. Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction. Circulation. 2024;150(11):867-883. doi:10.1161/circulationaha.124.068624
BibTeX
@article{Jheng2024,
author = {Jheng, Jia-Rong and Bai, Yang and Noda, Kentaro and Huot, Joshua R and Cook, Todd and Fisher, Amanda and Chen, Yi-Yun and Goncharov, Dmitry A and Goncharova, Elena A and Simon, Marc A and Zhang, Yingze and Forman, Daniel E and Rojas, Mauricio and Machado, Roberto F and Auwerx, Johan and Gladwin, Mark T and Lai, Yen-Chun},
title = {Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction},
journal = {Circulation},
year = {2024},
volume = {150},
number = {11},
pages = {867--883},
doi = {10.1161/circulationaha.124.068624}
}
EUVIMED